For IGF2BP2, ccRCC progression and metastasis can be inhibited by Circ-TNPO3 by binding directly to the IGF2BP2 protein and destabilizing the SERPINH1 mRNA [26]. The gene discussed is TNPO3; the disease is nonpapillary renal cell carcinoma.